Skip to content

Opening book details…

About this Medicine article

A5-02: Targeted therapy against VEGFR and/or EGFR signaling with AZD2171, vandetanib, and gefitinib as part of a combined modality approach for the treatment of non-small-cell lung cancer by O'Reilly, Michael S.; Furutani, Kazuhisa; Wu, Wenjuan; Onn, Amir; Ryan, Anderson; Jürgensmeier, Juliane M.; Komaki, Ritsuko; Herbst, Roy S. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
O'Reilly, Michael S.; Furutani, Kazuhisa; Wu, Wenjuan; Onn, Amir; Ryan, Anderson; Jürgensmeier, Juliane M.; Komaki, Ritsuko; Herbst, Roy S.
Publisher
Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 1556-1380)
Published
2007
Field
Medicine (Health Sciences)

More by O'Reilly, Michael S.; Furutani, Kazuhisa; Wu, Wenjuan; Onn, Amir; Ryan, Anderson; Jürgensmeier, Juliane M.; Komaki, Ritsuko; Herbst, Roy S.

Browse all works by O'Reilly, Michael S.; Furutani, Kazuhisa; Wu, Wenjuan; Onn, Amir; Ryan, Anderson; Jürgensmeier, Juliane M.; Komaki, Ritsuko; Herbst, Roy S.